All files for this dataset have been uploaded in a universal format (netcdf) onto a public repository which can be accessed using the following link: <http://datadryad.org/review?doi=doi:10.5061/dryad.s4617>.

Introduction {#sec001}
============

Ataxia telangiectasia (A-T) is a recessive genetic disorder of childhood that occurs in one out of 100,000 humans worldwide. A-T is a multi-system, progressive disorder associated with a high incidence of lymphoid malignancies \[[@pone.0151190.ref001]\]. Approximately 30--40% of A-T patients develop neoplasia during their life and more than 40% of all tumors in A-T patients are non-Hodgkin's lymphomas, \~20% acute lymphocytic leukemias, and 5% Hodgkin's lymphomas \[[@pone.0151190.ref002]--[@pone.0151190.ref006]\]. A-T patients suffer from compromised immune function, neurodegeneration, infections of the respiratory system, and increased mortality due to 1000-fold increase in malignancy \[[@pone.0151190.ref001], [@pone.0151190.ref007]--[@pone.0151190.ref009]\]. Although ground breaking studies have led to a better and deeper understanding of ataxia telangiectasia mutated (ATM) gene function \[[@pone.0151190.ref010], [@pone.0151190.ref011]\], no effective therapy is currently available to prevent cancer or progressive neurodegeneration.

Several laboratories have generated different strains of *Atm*-deficient (*Atm*^-/-^) mice and reported that *Atm*^*-/-*^ mice developed lymphomas and died between 2 and 5 months of age \[[@pone.0151190.ref012]--[@pone.0151190.ref016]\]. Later studies, including our own, showed that the onset of lymphoma can be drastically delayed till 7--12 months, which was not a result of genetic diversity \[[@pone.0151190.ref017]--[@pone.0151190.ref020]\]. Instead, it was found to be associated with changes in intestinal microbiota, including an increase in *Lactobacillus johnsonii* \[[@pone.0151190.ref021]\], and reduced lymphoma incidence was achieved by administering the antioxidant N-acetyl cysteine \[[@pone.0151190.ref019]\]. The inflammatory effect of normal intestinal microbiota compositions could shorten lifespan of mice compared to mice housed under sterile housing conditions. Subsequently, we generated *Atm*^*-/-*^ mice harboring different but well characterized intestinal microbiota, termed conventional microbiota (CM), and restricted microbiota (RM). Restricted microbiota harbor relatively few bacterial species, dominated by unclassified *Bacteroidetes*, and are free of known pathogens \[[@pone.0151190.ref022]\]. RM mice were originally obtained by Caesarean section and re-derived into the mouse colony with restricted flora adoptive mothers \[[@pone.0151190.ref023]\]. Sterile housing and a restriction of intestinal microbiota (in RM mice) yielded a 4.5-fold lower level of genetic instability, differences in acute leukocyte genotoxicity, inflammation markers, and a 2.5-fold delayed onset of lymphoma resulting in longevity as compared to mice with CM \[[@pone.0151190.ref021]\]. We further demonstrated that increased levels of *L*. *johnsonii* present in RM mice, led to low basal levels of chromosomal genotoxicity and inflammation in *Atm*^*-/-*^ mice compared to the CM mice \[[@pone.0151190.ref021], [@pone.0151190.ref024]\]. Given that energy metabolism has been implicated in oncogenesis, we hypothesized that the microbiome is likely to influence host metabolism resulting in an altered phenotype. In this study, we used a comparative fecal and urine metabolomics profiling approach to discern how either of the microbiota compositions, CM or RM, would impact the metabolic phenotype of *Atm*^*-/-*^ mice.

Gut microbiome are known to have a profound influence of a myriad of diseases including dementia, obesity and cancer, although the molecular implications of dysbiosis are yet to be elucidated \[[@pone.0151190.ref025]\]. For example, microbiota have been shown to influence energy metabolism, beta-oxidation of lipids, bile acid, glutamine and tryptophan metabolism, as well as oxidative stress and immune response metabolites \[[@pone.0151190.ref026], [@pone.0151190.ref027]\]. Most of recently reported studies focus on the regulatory and signaling pathways that are directly affected by microbiome in different patho-physiological conditions; however, there is a lack in studies that directly examine the metabolic consequences of alterations in gut microbiome.

Metabolomics is a qualitative and quantitative evaluation of alterations in endogenous metabolism in response to a specific perturbation in a biological system \[[@pone.0151190.ref028]\]. It represents the endpoint of genetic regulation and its impact on altered enzymatic activities and endogenous biochemical reactions in a cell \[[@pone.0151190.ref029]\]; thus characterizing precise changes in metabolism is likely to enable better understanding of how cells adapt to oxidative stress and minimize DNA damage and genomic instability. Moreover, correlation of metabolic profiles with gut microbiota offers to provide valuable insights into host-microbe interactions as well as valuable steps for achieving a breakthrough in personalized therapy paradigm \[[@pone.0151190.ref030]--[@pone.0151190.ref033]\]. Since ATM function influences cell signaling and metabolism \[[@pone.0151190.ref034]\], a metabolomics approach using isogenic mouse models differing only in microbiome composition should allow for a direct assessment of accumulated bacterial metabolites and the effects of the microbiome on metabolism \[[@pone.0151190.ref035]\].

Methods {#sec002}
=======

Reagents and standards {#sec003}
----------------------

Acetonitrile (ACN), methanol, and water (all LC-MS grade) were purchased from Fisher Scientific (NJ, USA). Debrisoquine, 4-nitrobenzoic acid (4-NBA), and heparin were purchased from Sigma (USA). All standard compounds used for tandem mass spectrometry based validation of metabolite identification were bought from Sigma. Lipid standards were ordered from Avanti Polar Inc. Other reagents for preparation and analyses of samples are described in the respective sections.

Animal housing and husbandry {#sec004}
----------------------------

The study was performed under the guidelines of the UCLA Animal Research Committee and specifically approved procedures for animal breeding, housing and sample collection in this study. Mice were housed under two types of specific pathogen free (SPF) conditions at UCLA Department of Laboratory and Animal Research, where either sterile (for RM), or non-sterile (for CM) food, water, and bedding were employed. *Atm*^*-/-*^ mice harboring RM and CM microbiota were created by rederivation as described in Fujiwara et al. \[[@pone.0151190.ref023]\], and by antibiotic treatment \[[@pone.0151190.ref036]\] followed by orogastric gavage of CM feces, respectively. The same procedures were applied in wild type mice. Mice of the RM colony were maintained under strictly aseptic and sterile conditions at the animal facility of the Radiation Oncology Department for several years. *Atm*^*-/-*^ mice were obtained by intercrossing *Atm*^*+/-*^ mice and identified by genotyping as previously described \[[@pone.0151190.ref021]\]. CM and RM mice for the metabolomics study were born in the respective colonies and were not treated with antibiotics. Urine and fecal samples from male *Atm*^*-/-*^ and *Atm*^*+/+*^ (referred to as wild type, or WT) mice aged 6--8 months were investigated by metabolomics-based molecular phenotyping. The different mice strains used in this study were defined as follows: *Atm*-KO-RM (Atm knock out mice carrying restricted microbiota); *Atm*-KO-CM (Atm knock out mice carrying conventional microbiota); WT-RM (wild type mice carrying restricted microbiota); and WT-CM (wild type mice carrying conventional microbiota). All urines and feces were separately collected in Eppendorf tubes from individual mice. The urine samples were centrifuged and the supernatant was aliquoted and frozen at -80°C until further use. All experiments were performed using at least 5 mice per genotype for metabolomics and at least 3--4 mice for 16S RNA sequencing experiments.

Intestinal bacterial analysis {#sec005}
-----------------------------

For this study, Illumina-based high-throughput sequencing of bacterial 16S rRNA genes from intestinal mucosa samples \[[@pone.0151190.ref037]\] was performed as described \[[@pone.0151190.ref038]\]. DNA was extracted from these samples using the PowerSoil DNA Isolation Kit (MO BIO Laboratories, Carlsbad, CA, USA), and a 30-second bead-beating step using a Mini-Beadbeater-16 (BioSpec Products, Bartlesville, OK, USA).

Metabolite extraction and metabolomics profiling {#sec006}
------------------------------------------------

Urine samples were processed as described previously \[[@pone.0151190.ref039]\] using 66% acetonitrile in water to precipitate any proteins or cellular debris. The samples were centrifuged, dried under vacuum, and stored at -80°C until analysis. Fecal samples were processed by initially sonicating in extraction solvent containing water and methanol (50% v/v) and internal standards, followed by addition of chloroform (1:1 v/v). The samples were centrifuged and the two biphasic layers were separated carefully. To each of the solvent phase two volumes of acetonitrile was added and mixed thoroughly by vortexing. The samples were incubated at -20°C for 4 hours to allow protein precipitation followed by centrifugation. The supernatant was combined and dried under vacuum, and resuspended in water containing 5% methanol for MS analysis.

Metabolites extracted from urine and fecal samples were analyzed in the same batch with two technical replicates for each sample to assess chromatographic reproducibility. The sample queue was randomized to avoid bias. Each sample (5 μl) was injected onto a reverse-phase 50 × 2.1 mm Acquity 1.7μm BEH C18 column (Waters Corp, Milford, MA), using an Acquity UPLC (Waters Corporation, USA) system online with an electrospray quadrupole time-of-flight tandem mass spectrometer (ESI-Q-TOF) (QTOF Premiere, Waters Corporation, USA). Positive and negative ion mode were operated; the details of tune page parameters have been described before \[[@pone.0151190.ref039], [@pone.0151190.ref040]\]. Together, we performed a broad range metabolite extraction and used reversed phase chromatography that would support the detection of a broad class of metabolites for urine and fecal samples. These data were normalized to the ion intensity of the internal standards (debrisoquine and 4, nitrobenzoic acid) and weight of the fecal pellet (for fecal samples), or creatinine (for urine samples). A 500 pg/μL solution of sulfadimethoxine in 50% acetonitrile (\[M + H\] ^+^, m/z 311.0814) was infused at 0.08 μL/min flow rate as the reference mass (lock mass) for accurate mass measurements. The quality control (QC) samples for each matrix comprised an aliquot of all samples in the study set, thus representing a universal set of metabolites. The QC sample was used to initially condition the column and thereafter, it was injected after every ten injections to account for reproducibility of the LC-MS data \[[@pone.0151190.ref041]\]. The coefficient of variance was examined for internal standards and creatinine in the QC samples and was found to be less than 15%. As explained above, five biological replicates per group were used for comparative profiling, while pooled QC samples were used for assessing technical reproducibility throughout each batch acquisition.

Statistical analysis of LC-MS data and Pathway Analysis {#sec007}
-------------------------------------------------------

The UPLC-QTOF raw data files were converted into NetCDF format (Network Common Data Form) using the MassLynx software (Waters Corp, Milford, MA). Subsequently, the LC-MS data were preprocessed using XCMS software as described \[[@pone.0151190.ref042]\]. The normalized data were processed using Metaboanalyst software (2.0) \[[@pone.0151190.ref043]\] and univariate analysis methods. Principal components analysis (PCA) was performed as an exploratory analysis to check for inter-group variability based on overall metabolite profiles. The candidate markers were selected by examining each volcano plot thereby considering fold change threshold of 2 and statistical p-value less than 0.05. A Benjamini-Hochberg correction was applied, which estimates conservative q-values \[[@pone.0151190.ref044]\], to ensure control of the false discovery rate (FDR) at a significance level of 0.05. Relative quantitation was achieved for molecular ions using the UPLC-QTOF system by taking a ratio of normalized intensity of the respective for the ions of interest in the comparative groups. This approach has been used by several laboratories including ours in previously reported studies \[[@pone.0151190.ref045]--[@pone.0151190.ref048]\]. The significant peaks from the FDR-adjusted analysis were putatively identified based on their m/z against Metabosearch, which performs accurate mass-based metabolite search through four main online databases; the Human Metabolome Database (HMDB), Lipid Maps, Madison Metabolomics Consortium Database (MMCD), and Metline \[[@pone.0151190.ref049]\]. The mass tolerance was kept at 5 parts per million to minimize false positive identification. The identity of metabolites was subsequently confirmed by comparisons of fragmentation spectra and retention time with commercially available standard compounds using tandem mass spectrometry (MS-MS). Signal intensities of the differentially abundant metabolites were visualized as a heat map, wherein the log transformed data were hierarchically clustered by Pearson correlation and average linkage clustering. The mean signal intensity is colored black, red indicates above-mean intensity, green denotes below-mean intensity and the degree of color saturation reflects the magnitude of intensity relative to the mean. Both, fecal and urine metabolomics data sets were analyzed using the Ingenuity Pathway Analysis (IPA) tool to score for correlative biochemical pathways.

Results {#sec008}
=======

RM mice have a distinct phylotype-reduced and pathogen-depleted intestinal microbiota composition compared to CM mice {#sec009}
---------------------------------------------------------------------------------------------------------------------

We created a mouse model with a selectively restricted microbiota, in which mice exhibit diminished T-cell immunity \[[@pone.0151190.ref037], [@pone.0151190.ref050]\], low risk for inflammatory infections, and high susceptibility to ionizing radiation in conjunction with proliferative pro-inflammatory T-cell signaling \[[@pone.0151190.ref022]\]. In prior research, the bacterial communities in feces from these mice were investigated by pyrosequencing of the bacterial 16S rRNA gene, and distinct profiles were identified for *Atm*^*-/-*^ and wild type mice bearing RM and CM microbiota, respectively \[[@pone.0151190.ref021], [@pone.0151190.ref022]\]. Since we have observed prolonged lifespans associated with a reduced number of B-cells in *Atm*^-/-^ RM mice \[[@pone.0151190.ref051]\], incidence of inflammatory non-Hodgkin B-cell lymphoma and neoplasia was suspected to be low. Consistent with these findings, pro-inflammatory *Helicobacter hepaticus*, another *Helicobacter* sp., and *Bacteroides stercoris* were less abundant or absent in RM mice compared to CM mice in mucosa samples of small intestine and colon ([Table 1](#pone.0151190.t001){ref-type="table"}). Advanced Illumina-based high-throughput sequencing was newly applied to the deep sequencing of intestinal samples from WT mice. We next investigated whether an onco-protective phenotype could be associated with differentially abundant metabolites detected in RM mice as compared to CM mice.

10.1371/journal.pone.0151190.t001

###### Bacterial phylotypes inhabiting the mucosa of small intestine and colon samples from CM and RM mice identified by high throughput Illumina analysis of the 16S rRNA gene.

![](pone.0151190.t001){#pone.0151190.t001g}

  ----------------------------------------------------------------------------------------------- -------- -------- -------
  **Nearest Cultured Relative (accession) (% identity) (Differentially abundant in intestine)**   **CM**   **RM**   **P**
  Unclassified Bacteroidetes (AY239461) (94% identity)                                            8%       49%      0.049
  *Barnesiella intestinihominis* (AB547647) (95% identity)                                        0%       4%       0.029
  **Nearest Cultured Relative (accession) (% identity) (Differentially abundant in colon)**       **CM**   **RM**   **P**
  *Helicobacter hepaticus* ATCC 51449 (NR_102911) (100% identity)                                 17%      0%       0.013
  *Helicobacter* sp. MIT 04--8588 (GU902718) (100% identity)                                      11%      0%       0.002
  *Bacteroides stercoris* (AB714307) (100% identity)                                              8%       0%       0.038
  Unclassified Bacteroidetes (AY239461) (94% identity)                                            12%      49%      0.003
  Unclassified Bacteroidetes (AY239461) (96% identity)                                            2%       5%       0.017
  ----------------------------------------------------------------------------------------------- -------- -------- -------

Values in CM and RM columns are % of Illumina rRNA gene reads from intestinal mucosal samples. These values were compared by 2-tailed Student's T-Tests. n = 3--4 mice for each of the two colonies. CM is conventional microbiota. RM is restricted microbiota. % identity was determined by analyses using Blast (NCBI) \[[@pone.0151190.ref069]\].

Microbiota drive changes in urinary metabolomics profiles in Atm^-/-^ and WT mice {#sec010}
---------------------------------------------------------------------------------

To investigate microbiota-associated metabolic alterations, we performed comparative metabolomic profiling of urine samples obtained from *Atm*^*-/-*^ or *Atm*^*+/+*^ (wild type, or WT) mice harboring either the RM or CM microbiota. Pre-processing using XCMS resulted in a three dimensional data matrix (m/z, retention time, and intensity values) consisting of a total of 1588 (*Atm*-KO-RM), 1672 (*Atm*-KO-CM), 1465 (WT-RM) and 1575 (WT-CM) features that were subsequently used for statistical analyses. Candidate markers were selected by examining the volcano plot and considering a fold change threshold of 2 and p-value less than 0.05 ([Fig 1](#pone.0151190.g001){ref-type="fig"}, Panels A and C). Principal component analysis resulted in a reasonable class separation of *Atm*-KO and WT groups harboring CM or RM microbiota, respectively ([Fig 1](#pone.0151190.g001){ref-type="fig"}, Panels B and D). The identity of some metabolites was confirmed using tandem mass spectrometry ([Table 2](#pone.0151190.t002){ref-type="table"}) and these are visualized as a heat map ([Fig 2](#pone.0151190.g002){ref-type="fig"}). For some other metabolites that came up as being significantly dysregulated on the volcano plots we were unable to find biological annotations in the databases. Interestingly, the presence of RM microbiota influenced both genotypes in a similar manner, although changes in the levels of urinary citrate were not significant for the WT mice. The urinary levels of 3-methylbutyrolactone were found to be high in *Atm*-KO-RM and WT-RM mice. Additionally, mice with RM microbiota also showed elevation of methyladenine, while the levels of metabolites like sarcosine, N-acetyl serine, and N-acetyl glutamine were depleted in mice of both genotypes with RM as compared to CM mice. Additionally, *Atm*-KO-RM mice showed upregulation of metabolites participating in TCA cycle like aconitic acid, and substituted amino acids as intermediary metabolites of purine like nicotinate D-ribonucleoside ([Table 3](#pone.0151190.t003){ref-type="table"}). WT-RM mice showed an increase in the urinary levels of N-phosphoacetyl-L-asparatic acid; a metabolite that has been shown to have a strong anti-tumor activity ([Table 4](#pone.0151190.t004){ref-type="table"}) \[[@pone.0151190.ref052]\]. Both genotypes of RM mice showed differential abundance of a number of di- and tripeptides differing in composition.

10.1371/journal.pone.0151190.t002

###### Validated urine metabolites that were differentially abundant in RM as compared to CM in Atm-KO and WT mice.

![](pone.0151190.t002){#pone.0151190.t002g}

  Name of the Metabolite   ESI Mode   m/z[\*](#t002fn001){ref-type="table-fn"}   RT [\*\*](#t002fn002){ref-type="table-fn"}   Atm KO   WT         Major CID Fragments                               
  ------------------------ ---------- ------------------------------------------ -------------------------------------------- -------- ---------- --------------------- ------- ---------- -------- ----------------------------
  Thymidine                POS        243.0998                                   4.0                                          **↑**    \<0.0001   0.0001                **↑**   0.0062     0.0129   170.0746, 172.0893
  3-Methylbutyrolacetone   POS        101.0603                                   1.2                                          **↑**    0.0001     0.0009                **↑**   0.0070     0.0131   55.05550, 73.0661, 83.0524
  Methyladenine            POS        150.0778                                   0.4                                          **↑**    0.0011     0.0037                **↑**   0.0166     0.0249   108.0446, 123.0674
  Citric acid              NEG        191.0182                                   0.3                                          **↑**    \<0.0001   0.0001                **↑**   0.0937     0.1125   85.0291, 87.0086, 111.0085
  Acetyl-L-glutamine       NEG        187.0717                                   0.3                                          **↓**    0.0001     0.0009                **↓**   \<0.0001   0.0002   125.0736, 145.0646
  Sarcosine                POS        90.0541                                    1.1                                          **↓**    0.4276     0.4528                **↓**   \<0.0001   0.0001   72.04
  N-Acetyl-Serine          NEG        146.0447                                   0.3                                          **↓**    0.0012     0.0039                **↓**   0.0006     0.0026   74.252, 84.0457, 98.0257

\* m/z = Mass/charge;

\*\* RT = Retention Time in minutes;

\*\*\* FC = Fold Change = RM/CM (≤ 0.5 or ≥ 2.0);

q-value = False Discovery Rate (FDR) adjusted p-value.

10.1371/journal.pone.0151190.t003

###### Urine metabolites that were differentially abundant in RM as compared to CM in only Atm-KO mice.

![](pone.0151190.t003){#pone.0151190.t003g}

  Metabolite Name                              ESI Mode   m/z[\*](#t003fn001){ref-type="table-fn"}   RT [\*\*](#t003fn002){ref-type="table-fn"}   Atm KO (Urine)   
  -------------------------------------------- ---------- ------------------------------------------ -------------------------------------------- ---------------- --------
  Aconitic acid                                NEG        173.0078                                   0.4                                          **↑**            0.0001
  N-Acetylornithine                            POS        175.1092                                   2.6                                          **↑**            0.0024
  O-Ureidohomoserine                           POS        178.0811                                   2.5                                          **↑**            0.0050
  Asn Asp                                      POS        248.0872                                   2.8                                          **↑**            0.0006
  Nicotinate D-ribonucleoside                  POS        256.0797                                   0.4                                          **↑**            0.0141
  Oleamide                                     POS        282.2785                                   8.0                                          **↓**            0.0316
  Glycylprolylhydroxyproline                   POS        286.1373                                   0.4                                          **↑**            0.0345
  Asp Gly Cys                                  POS        294.0773                                   0.9                                          **↑**            0.0061
  5-Thymidylic acid                            POS        307.0716                                   0.5                                          **↑**            0.0154
  Octanoylglucuronide                          NEG        319.1394                                   2.5                                          **↑**            0.0276
  Thr Thr Thr                                  POS        322.1586                                   4.8                                          **↑**            0.0151
  Phe Ala Asn                                  NEG        349.1504                                   3.7                                          **↑**            0.0495
  Ala His Glu                                  NEG        354.1398                                   4.9                                          **↓**            0.0004
  1-Phosphatidyl-D-myo-inositol                NEG        389.0529                                   1.9                                          **↓**            0.0023
  Met Ser Arg                                  POS        393.1943                                   2.7                                          **↑**            0.0010
  Lys-Phe-OH                                   NEG        400.1501                                   1.0                                          **↑**            0.0042
  Trp-Asp-OH                                   POS        442.1236                                   4.1                                          **↑**            0.0006
  Aspartyl-2-deoxy-adenosine-5-monophosphate   POS        447.0988                                   3.5                                          **↑**            0.0019
  serine hydroxamate-AMP                       NEG        448.0999                                   3.6                                          **↑**            0.0057
  Trp-Phe-OH                                   NEG        472.1521                                   3.7                                          **↓**            0.0098
  Arachidonoyl PAF C-16                        POS        768.5948                                   9.3                                          **↑**            0.0453
  GPCho(18:2/18:2)                             NEG        781.5600                                   5.1                                          **↓**            0.0038

\* m/z = Mass/charge;

\*\* RT = Retention Time in minutes;

\*\*\* FC = Fold Change = RM/CM (≤ 0.5 or ≥ 2.0).

10.1371/journal.pone.0151190.t004

###### Urine metabolites that were differentially abundant in RM as compared to CM in only WT mice.

![](pone.0151190.t004){#pone.0151190.t004g}

  Metabolite Name                           ESI Mode   m/z[\*](#t004fn001){ref-type="table-fn"}   RT [\*\*](#t004fn002){ref-type="table-fn"}   WT (Urine)   
  ----------------------------------------- ---------- ------------------------------------------ -------------------------------------------- ------------ --------
  Dihydroxyquinoline                        POS        162.0544                                   2.0                                          **↓**        0.0005
  Hydroxyadipic acid                        POS        163.0604                                   2.2                                          **↓**        0.0004
  m-Hydroxyhippuric acid                    NEG        194.0452                                   2.8                                          **↓**        0.0005
  Dopaquinone                               NEG        194.0470                                   0.6                                          **↑**        0.0002
  Decenedioic acid                          NEG        199.0984                                   4.6                                          **↓**        0.0261
  Pantothenic Acid                          POS        220.1173                                   1.1                                          **↑**        0.0000
  N-acetyl-beta-D-glucosaminylamine         POS        221.1116                                   1.1                                          **↓**        0.0000
  N-octanoyl-L-Homoserine lactone           NEG        226.1432                                   5.4                                          **↓**        0.0220
  Ser Lys                                   POS        234.1455                                   4.2                                          **↓**        0.0254
  Tiglylcarnitine                           NEG        242.1391                                   4.9                                          **↓**        0.0176
  N-phosphonoacetyl-L-ornithine             NEG        253.0608                                   2.9                                          **↓**        0.0146
  N-phosphonoacetyl-L-aspartic acid         NEG        254.0061                                   1.6                                          **↑**        0.0061
  Asn Gln                                   NEG        259.1026                                   4.5                                          **↓**        0.0004
  3-Methoxy-4-hydroxyphenylglycol sulfate   NEG        263.0237                                   0.8                                          **↑**        0.0298
  Ala Ala Lys                               NEG        287.1707                                   4.9                                          **↓**        0.0473
  Thr Ala Thr                               POS        292.1512                                   4.2                                          **↓**        0.0229
  2-Oxo-nonadecanoic acid                   POS        313.2717                                   8.1                                          **↓**        0.0001
  Gly Met Asn                               POS        321.1234                                   3.9                                          **↓**        0.0409
  Cys Asp Cys                               NEG        338.0512                                   1.1                                          **↓**        0.0033
  Val Thr Glu                               NEG        346.1650                                   5.8                                          **↓**        0.0198
  Thr-Asp-OH                                NEG        355.0807                                   4.0                                          **↑**        0.0000
  Asn Ser His                               NEG        355.1383                                   5.0                                          **↓**        0.0067
  Cys Val His                               NEG        356.1388                                   5.0                                          **↓**        0.0050
  Cys Pro Phe                               POS        366.1511                                   2.1                                          **↓**        0.0005
  Ala Tyr Asn                               POS        367.1609                                   2.1                                          **↓**        0.0004

\* m/z = Mass/charge;

\*\* RT = Retention Time in minutes;

\*\*\* FC = Fold Change = RM/CM (≤ 0.5 or ≥ 2.0).

![Urine metabolomics in RM and CM mouse models.\
Panel A and C. Volcano plots facilitating visualization of differentially abundant metabolites that were selected based on fold change (X-axis) and p-value in (Y-axis) for Atm-KO and WT mice, respectively. The m/z values highlighted in pink have a fold change of ≥ 0.5 or ≤ 2.0 and p-value ≤ 0.05 in RM as compared to CM mice and were selected for further characterization. Panel B and D: PCA plots showing separation between RM and CM in Atm-KO and WT mice, respectively.](pone.0151190.g001){#pone.0151190.g001}

![Heat map showing differential abundance of urine metabolites in the various study groups: Metabolites profiles for Atm-KO-CM group, Atm-KO-RM, WT-CM, and WT-RM, respectively.\
Each column represents a sample, and each row represents a metabolite. The mean signal intensity of CM group is colored black; red indicates above-mean intensity, green denotes below mean intensity, and the degree of color saturation reflects the magnitude of intensity relative to the mean.](pone.0151190.g002){#pone.0151190.g002}

Microbiota drive alterations in the fecal metabolome in Atm^-/-^ and WT mice {#sec011}
----------------------------------------------------------------------------

Next we performed metabolomic profiling of fecal samples obtained from *Atm*^*-/-*^ or wild type (WT) mice harboring either the RM or CM microbiota. Pre-processing using XCMS resulted in 1478 (*Atm*-KO-RM), 1742 (*Atm*-KO-CM), 1655 (WT-RM) and 1675 (WT-CM) features that were subjected to multivariate analyses. Putative markers were selected by examining the volcano plot and considering a fold change threshold of 2 and p-value less than 0.05 ([Fig 3](#pone.0151190.g003){ref-type="fig"}, Panels A and C). Again, principal component analysis resulted in clear separation of *Atm*^*-/-*^ and WT groups harboring CM or RM microbiota, respectively ([Fig 3](#pone.0151190.g003){ref-type="fig"}, Panels B and D). The identity of these metabolites was confirmed using tandem mass spectrometry ([Table 5](#pone.0151190.t005){ref-type="table"}). Metabolites identified from individual difference detection analyses were visualized as a heat map ([Fig 4](#pone.0151190.g004){ref-type="fig"}). *Atm*-KO and WT-RM mice showed statistically significant upregulation of a number of metabolites including homophenylalanine, sphinganine, methyluridine and riboflavin sodium phosphate. There was an elevation in the levels of kynurenic acid (a tryptophan metabolite) \[[@pone.0151190.ref053]\]. RM mice also showed elevation in the fecal levels of riboflavin phosphate (Vitamin B2), which is a precursor of flavin adenine dinucleotide (FAD) and flavin adenine mononucleotide (FMN) that are essential cofactors of TCA cycle. In addition, *Atm*-KO-RM mice showed alterations in relative abundance of free fatty acids, secondary bile acids as well as tripeptides as compared to the *Atm*-KO-CM mice ([Table 6](#pone.0151190.t006){ref-type="table"}). WT-RM mice showed differentials levels of a number of glycerophospholipids, di- and tripeptides as well as fatty acids ([Table 7](#pone.0151190.t007){ref-type="table"}).

10.1371/journal.pone.0151190.t005

###### Validated fecal metabolites that were differentially abundant in RM as compared to CM in the Atm-KO and WT mice.

![](pone.0151190.t005){#pone.0151190.t005g}

  Metabolite Name                      ESI Mode   m/z[\*](#t005fn001){ref-type="table-fn"}   RT [\*\*](#t005fn002){ref-type="table-fn"}   Atm KO   WT         Major CID Fragments                               
  ------------------------------------ ---------- ------------------------------------------ -------------------------------------------- -------- ---------- --------------------- ------- ---------- -------- -----------------------------
  Palmitoyl-Ethanolamide               POS        300.2896                                   2.5                                          **↑**    0.0053     0.0119                **↑**   0.0083     0.0131   62.0612, 95.0872
  Homophenylalanine                    POS        180.1006                                   0.9                                          **↑**    0.0046     0.0113                **↑**   0.0007     0.0031   97.0512, 117.0698
  3-Methyluridine                      NEG        257.0775                                   0.4                                          **↑**    0.0003     0.0013                **↑**   \<0.0001   0.0003   82.03001, 154.0508,
  214.0718                                                                                                                                                                                                      
  O-Benzyl-L-Tyrosine                  POS        272.1296                                   0.4                                          **↑**    0.0009     0.0033                **↑**   0.006      0.0129   91.0553, 226.1236, 255.1023
  Dihydroceramide C2                   POS        344.3183                                   3.1                                          **↑**    0.0023     0.007                 **↑**   0.0078     0.0131   81.0711, 95.0867, 266.2828
  Sphinganine                          POS        302.3049                                   2.5                                          **↑**    0.0011     0.0037                **↑**   0.008      0.0131   91.0552, 254.2855
  3-hydroxyphenyl-Arachidonoyl amide   POS        396.2922                                   3.7                                          **↑**    \<0.0001   0.0003                **↑**   0.0601     0.0738   110.0616, 203.1800
  Kynurenic acid                       NEG        188.0365                                   1.7                                          **↑**    0.0171     0.025                 **↑**   0.1489     0.1711   144.044
  Cytidine                             NEG        242.0764                                   1.2                                          **↑**    0.0429     0.0538                **↑**   0.0405     0.0521   109.0395
  Riboflavin sodium phosphate          NEG        477.0794                                   0.3                                          **↑**    0.0261     0.0371                **↑**   0.1368     0.1606   78.9596, 96.9696
  Thymine                              POS        127.0495                                   0.6                                          **↑**    0.031      0.043                 **↑**   0.0391     0.0515   84.0450, 110.0238
  Isonicotinic acid                    POS        124.0405                                   0.4                                          **↑**    0.1739     0.1956                **↑**   0.0322     0.0434   80.0504, 96.0450,
  124.0398                                                                                                                                                                                                      
  Adenosine                            POS        268.1035                                   0.6                                          **↑**    0.2196     0.2371                **↑**   0.0082     0.0131   94.0413, 136.0631
  LysoPE(18:1(9Z)/0:0)                 NEG        478.2967                                   3.5                                          **↓**    0.2118     0.2334                **↓**   0.0045     0.0113   78.9599, 281.2458

\* m/z = Mass/charge;

\*\* RT = Retention Time in minutes;

\*\*\* FC = Fold Change = RM/CM (≤ 0.5 or ≥ 2.0);

q-value = False Discovery Rate (FDR) adjusted p-value.

10.1371/journal.pone.0151190.t006

###### Fecal metabolites that were differentially abundant in RM as compared to CM only in Atm-KO mice.

![](pone.0151190.t006){#pone.0151190.t006g}

  Metabolite Name                                                                ESI Mode   m/z[\*](#t006fn001){ref-type="table-fn"}   RT [\*\*](#t006fn002){ref-type="table-fn"}   Atm KO (Fecal)   
  ------------------------------------------------------------------------------ ---------- ------------------------------------------ -------------------------------------------- ---------------- --------
  L-Methionine                                                                   NEG        148.0432                                   0.4                                          **↓**            0.0014
  Tryptophan                                                                     POS        205.0965                                   1.6                                          **↓**            0.0374
  Hydroxydecanedioic acid                                                        NEG        217.1082                                   2.4                                          **↓**            0.0231
  6-Acetyl-D-glucose                                                             NEG        221.0687                                   1.5                                          **↓**            0.0053
  9,12-Dioxo-dodecanoic acid                                                     NEG        227.1280                                   3.4                                          **↓**            0.0357
  Malonylcarnitine                                                               POS        248.1122                                   0.4                                          **↓**            0.0078
  AFMK (Acetyl-N-formyl-5-methoxykynurenamine)                                   NEG        263.1011                                   2.3                                          **↓**            0.0035
  Heptanoylcarnitine                                                             NEG        272.1844                                   2.9                                          **↓**            0.0068
  trans-Farnesyl phosphate                                                       NEG        301.1586                                   3.1                                          **↓**            0.0243
  Ser Arg Gly                                                                    NEG        317.1577                                   2.9                                          **↓**            0.0213
  Ser Lys Ser                                                                    NEG        319.1647                                   3.0                                          **↓**            0.0044
  Met Val Ala                                                                    POS        320.1669                                   2.9                                          **↓**            0.0299
  Phe Arg                                                                        NEG        320.1700                                   3.0                                          **↓**            0.0050
  Eicosapentaenoyl ethanolamide                                                  POS        346.2734                                   3.1                                          **↓**            0.0237
  Cys Gln Cys                                                                    POS        353.0977                                   2.7                                          **↓**            0.0143
  DHA ethyl ester                                                                POS        357.2794                                   4.3                                          **↓**            0.0465
  3-Oxo-chol-11-enic acid                                                        POS        373.2752                                   3.8                                          **↓**            0.0425
  Ile Thr Phe                                                                    POS        380.2167                                   7.5                                          **↓**            0.0465
  Hydroxytetracosenoic acid                                                      NEG        381.3370                                   8.4                                          **↑**            0.0158
  His Asp Asn                                                                    NEG        383.1299                                   2.8                                          **↓**            0.0002
  Allochenodeoxycholic acid                                                      NEG        391.2852                                   4.3                                          **↓**            0.0175
  Vitamin D6                                                                     POS        411.3633                                   6.7                                          **↑**            0.0474
  Lys His Met                                                                    POS        415.2148                                   4.8                                          **↓**            0.0257
  Lys-Tyr-OH                                                                     NEG        416.1451                                   1.5                                          **↓**            0.0239
  PA(17:1/0:0)                                                                   POS        423.2508                                   7.9                                          **↓**            0.0269
  His Phe Met                                                                    NEG        432.1713                                   1.1                                          **↓**            0.0127
  PE(P-16:0/0:0)                                                                 NEG        436.2817                                   6.0                                          **↑**            0.0283
  Met Met Arg                                                                    POS        437.1989                                   4.8                                          **↓**            0.0268
  PC(P-14:0/0:0)                                                                 NEG        450.3013                                   3.3                                          **↓**            0.0171
  (22R)-1a,22,25-Trihydroxy-23;24-tetradehydro-24a,24b-dihomo-20-epivitamin D3   NEG        455.3139                                   5.3                                          **↓**            0.0239
  Trp Trp Ala                                                                    POS        462.2094                                   3.8                                          **↓**            0.0222
  PA(22:2(13Z,16Z)/0:0)                                                          NEG        489.2991                                   3.2                                          **↓**            0.0050
  Trp Asp Trp                                                                    POS        506.2044                                   4.0                                          **↓**            0.0239
  D-Urobilinogen                                                                 POS        591.3198                                   3.1                                          **↓**            0.0100
  Atalanine                                                                      POS        611.2065                                   9.3                                          **↓**            0.0006
  PA(P-16:0/15:1(9Z))                                                            POS        617.4588                                   8.2                                          **↓**            0.0067
  Cer(d18:0/24:0)                                                                POS        652.6553                                   9.0                                          **↓**            0.0186
  PG(14:1(9Z)/14:1(9Z))                                                          POS        663.4281                                   8.2                                          **↓**            0.0050
  Palmitoyl thio-PC                                                              POS        750.5451                                   9.4                                          **↓**            0.0484
  PA(18:1/22:4)                                                                  POS        751.5342                                   9.4                                          **↓**            0.0475
  MGDG(18:2/18:3)                                                                POS        777.5552                                   9.4                                          **↓**            0.0426
  PI(P-16:0/16:1)                                                                POS        793.5189                                   8.3                                          **↓**            0.0035
  16:2-Glc-Campesterol                                                           POS        797.6345                                   8.9                                          **↓**            0.0103
  PG(18:1/20:2)                                                                  POS        801.5637                                   8.9                                          **↓**            0.0049
  PC(16:1/22:6)                                                                  POS        804.5513                                   8.0                                          **↓**            0.0488

\* m/z = Mass/charge;

\*\* RT = Retention Time in minutes;

\*\*\* FC = Fold Change = RM/CM (≤ 0.5 or ≥ 2.0).

10.1371/journal.pone.0151190.t007

###### Fecal metabolites that were differentially abundant in RM as compared to CM only in WT mice.

![](pone.0151190.t007){#pone.0151190.t007g}

  Name of Unique Metabolite ID                   ESI Mode   m/z[\*](#t007fn001){ref-type="table-fn"}   RT [\*\*](#t007fn002){ref-type="table-fn"}   WT (Fecal)   
  ---------------------------------------------- ---------- ------------------------------------------ -------------------------------------------- ------------ --------
  Alanine                                        POS        90.0550                                    0.3                                          **↓**        0.0037
  3-Amino-alanine                                POS        106.0743                                   8.5                                          **↑**        0.0428
  Hydroxybenzoquinone                            POS        125.0230                                   0.4                                          **↓**        0.0283
  4-Hydroxyquinoline                             NEG        144.0448                                   2.5                                          **↓**        0.0036
  Orotic acid                                    NEG        155.0106                                   0.4                                          **↓**        0.0110
  Acetyl-DL-Valine                               NEG        158.0810                                   1.5                                          **↓**        0.0232
  2-Hydroxylamino-4,6-dinitrotoluene             NEG        212.0314                                   0.4                                          **↓**        0.0020
  3-Methoxytyrosine                              POS        212.0930                                   1.3                                          **↓**        0.0043
  N-Acetyl-beta-D-glucosaminylamine              POS        221.1112                                   1.4                                          **↓**        0.0438
  L-4-Hydroxy-3-methoxy-a-methylphenylalanine    POS        226.1071                                   1.5                                          **↓**        0.0118
  Gamma-glutamyl-proline                         NEG        242.1136                                   2.3                                          **↓**        0.0238
  Palmitic acid                                  NEG        255.2318                                   7.4                                          **↓**        0.0176
  Asp Gln                                        POS        262.1058                                   0.4                                          **↓**        0.0217
  AFMK (Formyl-N-acetyl-5-methoxykynurenamine)   POS        265.1202                                   2.3                                          **↓**        0.0316
  N-Acetyl-L-glutamate 5-phosphate               NEG        268.0202                                   0.3                                          **↓**        0.0018
  Isovalerylglucuronide                          NEG        277.0919                                   1.3                                          **↑**        0.0068
  2-methyl-16-heptadecenoic acid                 NEG        281.2480                                   7.5                                          **↓**        0.0374
  Met Gly Ser                                    NEG        292.0972                                   0.5                                          **↓**        0.0019
  C20:4n-2;6;9;12                                NEG        303.2316                                   7.0                                          **↓**        0.0484
  Arachidic acid                                 NEG        311.2976                                   8.4                                          **↓**        0.0106
  3-Oxo-nonadecanoic acid                        POS        313.2747                                   7.0                                          **↓**        0.0010
  His Gly Cys                                    POS        316.1097                                   0.6                                          **↓**        0.0258
  Ser Pro Asp                                    NEG        316.1165                                   0.6                                          **↑**        0.0161
  Leu Trp                                        POS        318.1815                                   2.4                                          **↓**        0.0433
  Hydroxysphinganine                             POS        318.3007                                   4.9                                          **↑**        0.0122
  His Leu Gly                                    POS        326.1834                                   1.7                                          **↓**        0.0130
  Docosanoic acid                                NEG        339.3246                                   8.8                                          **↓**        0.0428
  2,3-dinor Thromboxane B1                       NEG        343.2122                                   2.9                                          **↑**        0.0345
  Leu Thr Leu                                    NEG        344.2169                                   2.9                                          **↑**        0.0099
  18-Oxo-resolvin E1                             NEG        347.1878                                   3.2                                          **↓**        0.0391
  Coutaric acid                                  NEG        348.1907                                   3.2                                          **↓**        0.0400
  S-(2-Hydroxyethyl)glutathione                  NEG        350.1028                                   0.5                                          **↑**        0.0177
  MG(0:0/18:3/0:0)                               NEG        351.2510                                   8.0                                          **↓**        0.0012
  13,14-Dihydro PGF-1a                           NEG        357.2618                                   3.7                                          **↑**        0.0211
  His Asn Cys                                    NEG        371.1180                                   2.7                                          **↓**        0.0307
  Pro Glu Met                                    NEG        374.1379                                   7.4                                          **↓**        0.0302
  Pro His Glu                                    NEG        380.1610                                   7.0                                          **↓**        0.0434
  Lys-Lys-OH                                     NEG        381.1748                                   7.5                                          **↓**        0.0461
  Pentacosanoic acid                             NEG        381.3723                                   9.5                                          **↓**        0.0369
  Val Glu His                                    NEG        382.1763                                   7.5                                          **↓**        0.0456
  S-Adenosylhomocysteine                         NEG        383.1160                                   0.5                                          **↑**        0.0014
  Glu Phe Val                                    POS        394.1940                                   2.0                                          **↓**        0.0232
  Hexacosanoic acid                              NEG        395.3859                                   9.9                                          **↓**        0.0415
  PC(O-12:0/0:0)                                 NEG        424.2795                                   3.3                                          **↓**        0.0003
  Glu Arg Glu                                    NEG        431.1883                                   4.8                                          **↓**        0.0077
  Palmityl myristoleate                          NEG        449.4324                                   10.6                                         **↓**        0.0452
  PE(O-18:0/0:0)                                 POS        468.3489                                   6.6                                          **↑**        0.0054
  Sulfocholic acid                               NEG        487.2420                                   3.9                                          **↓**        0.0111
  Hydroxydydrogesterone glucuronide              NEG        489.2540                                   3.9                                          **↓**        0.0109
  Glycochenodeoxycholate 7-sulfate               NEG        528.2599                                   2.3                                          **↓**        0.0269
  Trp Arg Trp                                    NEG        545.2651                                   4.1                                          **↓**        0.0228
  DG(16:0/16:0/0:0)                              POS        569.5133                                   9.4                                          **↑**        0.0031
  Ceramide (d18:0/20:0)                          POS        596.5966                                   10.6                                         **↑**        0.0451
  PG(O-16:0/12:0)                                NEG        651.4610                                   7.9                                          **↓**        0.0037
  PG(14:0/14:0)                                  NEG        665.4351                                   7.5                                          **↓**        0.0318
  Ceramide (t18:0/24:0)                          POS        668.6561                                   10.1                                         **↑**        0.0297

\* m/z = Mass/charge;

\*\* RT = Retention Time in minutes;

\*\*\* FC = Fold Change = RM/CM (≤ 0.5 or ≥ 2.0).

![Gut microbiota modulates fecal metabolomic profiles in Atm-KO and WT mice.\
Panel A and C. Volcano plots facilitating visualization of differentially abundant metabolites that were selected based on fold change (X-axis) and p-value in (Y-axis) for Atm-KO and WT mice, respectively. The m/z values highlighted in pink have a fold change of ≥ 0.5 or ≤ 2.0 and p-value ≤ 0.05 in RM as compared to CM mice and were selected for further characterization. Panels B and D: PCA plots showing separation between RM and CM in Atm-KO and WT mice, respectively.](pone.0151190.g003){#pone.0151190.g003}

![Heat map showing differential abundance of fecal metabolites in various study groups (Panels A-D): Metabolites profiles for Atm-KO-CM group, Atm-KO-RM, WT-CM, and WT-RM, respectively.\
Each column represents a sample, and each row represents a metabolite. The mean signal intensity of CM group is colored black; red indicates above-mean intensity, green denotes below mean intensity, and the degree of color saturation reflects the magnitude of intensity relative to the mean.](pone.0151190.g004){#pone.0151190.g004}

In order to gain insights into metabolite enrichment representing specific molecular networks and pathway perturbations caused by changes in gut microbiome in *Atm*- KO mice, we used the Ingenuity Pathway Analysis (IPA) tool. This was achieved by integrating the fecal and urine metabolomics data sets that were initially scored separately for differentially expressed metabolites. Pathway analysis showed positive correlation for metabolic intermediates of TCA cycle in RM as compared to CM in *Atm*-KO mice ([Fig 5](#pone.0151190.g005){ref-type="fig"} Panel A). Examination of molecular networks revealed an upregulation of TP53 regulated metabolite networks ([Fig 5](#pone.0151190.g005){ref-type="fig"} Panel B). Although these networks may affect a broad range of cellular processes, they can be considered distinct key metabolites that help explain the observed phenotype in these mice. Further investigations into more specific metabolite changes may answer to the basic question of precisely how do changes in microbiota composition result in an onco-protective phenotype.

![Functional Pathway Analysis showing major upregulated pathways in Atm-KO mice with RM as compared to CM microbiota.\
Panel A shows significantly perturbed canonical pathways in Atm-KO-RM mice, while Panel B shows a TP53 regulated network that correlated strongly with metabolic profiles of Atm-KO-RM mice.](pone.0151190.g005){#pone.0151190.g005}

Discussion {#sec012}
==========

Despite increasing efforts in the field of A-T research, the mechanisms by which enteric microbiota lead to changes in *Atm*-mediated lymphomagenesis remain elusive. ATM regulates the cellular response to oxidative stress and it senses double-stranded DNA breaks, thus inhibiting cell cycle progression \[[@pone.0151190.ref011], [@pone.0151190.ref054]\]. It has been demonstrated that intestinal microbiota can induce cancer development \[[@pone.0151190.ref035]\], for example *Helicobacter pylori*, inducing gastric cancer and lymphoma in WT mice and humans, as well as potentially influencing the response of cancer to therapies \[[@pone.0151190.ref055], [@pone.0151190.ref056]\]. We have previously shown reduction of cancer susceptibility and an impact on longevity by specific alterations in gut microbiota composition in *Atm*^*-/-*^ mice. Using an untargeted, high resolution mass spectrometry approach, we then asked how this translates into metabolic changes in mice that are genetically identical but differ only in their gut microbiome composition. Surprisingly, we did not find differently abundant metabolites in blood profiles (data not shown). Moreover, our results from the analysis of urine and fecal samples suggest that distinct intestinal microbiota cause a metabolic shift towards the upregulation of metabolites including kyneurenic acid, methyladenine and 3-methybutyrolactone that may attenuate cancer-promoting signaling pathways, reported to be associated with an onco-protective phenotype independent of the genotype of the mice. We found that intestinal microbiota restriction in Atm-deficient mice led to a 2.5-fold extension of lymphoma latency and 4 fold increased longevity, and significant differences in chromosomal genotoxicity, oxidative DNA damage and inflammation; our research was the first to show a relationship between intestinal microbiota and lymphoma onset \[[@pone.0151190.ref021]\]. *Lactobacillus johnsonii*, one of the indicator phylotypes that we identified to be more abundant in RM than CM mice, is known to increase the number of Paneth cells, which are a host cell type that produces antimicrobial compounds, and are located together with stem cells in the intestinal crypt \[[@pone.0151190.ref057]\]. The extended lifespans of our RM mouse models appear to be caused by an intestinal microbiota comprised largely of unclassified members of the Bacteroidetes ([Table 1](#pone.0151190.t001){ref-type="table"}), which in turn result in specific metabotypes.

Potentially chemopreventive metabolites were found to be differentially abundant in a microbiota-dependent manner in *Atm*-KO or WT mice; for example, the urinary levels of 3-methylbutyrolactone were elevated in both genotypes harboring RM microbiota. This metabolite is known to be produced by the intestinal bacteria and exhibits strong anti-aromatase properties \[[@pone.0151190.ref058]\]. Further, this metabolite inhibits fatty acid synthase (FAS), which activates carnitine palmitoyltransferase 1beta (CPT-1beta) and ultimately results in beta-oxidation of long chain fatty acids and prevention of lipid accumulation \[[@pone.0151190.ref059]\]. In addition, alpha-methylbutyrolactone acts as a selective alkylating agent for thiol rich enzymes like phosphofructokinase, DNA polymerase and glycogen synthase; thus regulating cell proliferation \[[@pone.0151190.ref060]\]. Additionally, mice with RM microbiota showed elevation of methyladenine, which is a potent inhibitor of phosphoinositide 3-kinases (PI3K) and has also been shown to exhibit tumor suppressor activity \[[@pone.0151190.ref061]--[@pone.0151190.ref064]\]. There was an elevation in the levels of kynurenic acid (a tryptophan metabolite) in feces of RM mice. Walczak et al. have reported the potential chemopreventative role of this metabolite in colon cancer \[[@pone.0151190.ref053]\]. Elevation of kynurenic acid has been shown to positively correlate with immune tolerance \[[@pone.0151190.ref065]--[@pone.0151190.ref067]\]. An upregulation of metabolites participating in oxidative phosphorylation was found in RM as compared to CM in *Atm*- KO ([Fig 5](#pone.0151190.g005){ref-type="fig"}, Panel A) mice, as well as an upregulation of TP53 regulated molecular networks in RM mice ([Fig 5](#pone.0151190.g005){ref-type="fig"}, Panel B). Interestingly, TP53 is known to regulate the expression of TIGAR (TP53-induced Glycolysis and Apoptosis Regulator) that has been shown to downregulate glycolysis by lowering the endogenous levels of fructose 1,6 biphosphate \[[@pone.0151190.ref068]\]. This is an interesting finding, generating new hypothesis for investigating how alleviation of glycolytic phenotype in RM mice is induced. Future investigations in our laboratory will specifically follow the molecular links and associations proposed herein.

Our results demonstrate that microbiome composition leads to specific changes in overall host metabolism, which may have direct implications on phenotype. This proof of principle investigation opens up several relevant and challenging questions; particularly, how lipids measured in feces of these mice indirectly regulate apoptosis, or if the altered metabolic profile accounts at least in part for extended life and decreased incidence of carcinogenesis in eukaryotes and will be a part of future studies. Further investigation is also needed to specify the regulatory role of certain microbiota compositions in permitting genotoxicity by reducing local or systemic autophagy.

In conclusion, our pilot study demonstrates metabolite profiles likely modulated by specific phylotypes in RM mice that correlate with our previously reported observations of decreased tumor incidence and general leukocyte genotoxicity in RM mice as compared to *Atm*-KO-CM mice \[[@pone.0151190.ref021]\]. These alterations in the mean abundance of the interrogated metabolites, including 3-methylbutyrolactone and 3-methyadenine ([Fig 2](#pone.0151190.g002){ref-type="fig"}) and kynurenic acid ([Fig 4](#pone.0151190.g004){ref-type="fig"}) were more pronounced in *Atm*-KO mice as compared to the WT RM mice, which may help explain genotype based susceptibility. Together, these findings lend credence to the notion that manipulating microbial composition could be used as an effective strategy to prevent or alleviate cancer susceptibility. The onco-protective effect of RM microbiota is true for WT as well as *Atm*-KO mice---the only difference lies in cancer susceptibility for both genotypes. Remarkably, our findings suggest that composition of the gut microbiota influences and alters central carbon metabolism in a genotype independent manner. In future, it is our hope that the use of probiotics-containing RM would be a potential chemopreventive for normal humans, while the same type of microbiota would decrease tumor incidence in cancer susceptible populations.
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A-T

:   Ataxia telangiectasia

RM

:   Restricted microbiota

CM

:   Conventional microbiota

KO

:   Knockout

UPLC

:   Ultra performance liquid chromatography

LC-MS

:   Liquid chromatography-mass spectrometry

TCA

:   Tricarboxylic acid
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